Stephen Ansell, MD, PhD
Enriched profileProfessor of Medicine, Mayo Clinic College of Medicine and Science; Chair, Division of Hematology; Chair, Lymphoma Disease Group; Dorotha W. and Grant L. Sundquist Professor in Hematologic Malignancies Research; Consultant, Division of Hematology, Mayo Clinic · Mayo Clinic
Stephen Ansell is Professor of Medicine, Mayo Clinic College of Medicine and Science; Chair, Division of Hematology; Chair, Lymphoma Disease Group; Dorotha W. and Grant L. Sundquist Professor in Hematologic Malignancies Research; Consultant, Division of Hematology, Mayo Clinic at Mayo Clinic. OpenAlex indexes 1,478 publications with 52,585 citations (h-index 113); ClinicalTrials.gov lists 10 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Hematology profiles in the findmyKOL directory. Clarivate lists Stephen Ansell as a Highly Cited Researcher (Clinical Medicine, 2020-2021).
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Stephen Ansell, M.D., is Professor of Medicine, Mayo Clinic College of Medicine and Science. The public record shows 1,478 publications with 52,585 citations (h-index 113), centered on Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research. It also documents an investigator role on 10 registered clinical trials, industry payments reported by 2 companies, 4 NIH-funded awards (2002–2024).
- Most recent indexed publication: 2026 · British journal of haematology
- Top research focus: Lymphoma Diagnosis and Treatment
- 10 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 82 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 541.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 10 registered studies on ClinicalTrials.gov. The most recent:
- Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas
Sponsor: National Cancer Institute (NCI)
Industry payments
Updated 27 Aug 2026
2 companies reported payments to CMS in program years 2022–2024. These are public disclosures, not judgments. The latest:
- Takeda Pharmaceuticals U.S.A., Inc.Program year20245 payments$10,114openpaymentsdata.cms.gov ↗
- AstraZeneca Pharmaceuticals LPProgram year20232 payments
- AstraZeneca Pharmaceuticals LPProgram year20224 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
98.7%Other drugs affecting bone structure and mineralization98.7%Romosozumab-aqqg100%Part B, office-administered≥11 patientsDermatology
0.8%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor0.8%Acyclovir100%Part D<11 patientsBlood & clotting
0.5%Other systemic hemostatics0.5%Doptelet100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
4 NIH research awards on record, funded 2002–2024 per NIH RePORTER. The latest:
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Lymphocyte dynamics after CAR-T therapy for non-Hodgkin lymphoma.
British journal of haematology
Article2026 - No association of prior administration of selected vaccines with lymphoma prognosis.
Cancer epidemiology, biomarkers & prevention
Article2026 - High Soluble Tumor Necrosis Factor Receptor 2 in Serum Is Associated With Inferior Overall Survival Across Major Lymphoma Subtypes.
American journal of hematology
Article2026
Most-cited works
by citation count (OpenAlex)Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/stephen-ansell-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- LinkedIn
linkedin.com/posts/mayo-clinic_the-american-society-of-hematology-recognizes-activity-6882437883878232064-51bN
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
mayoclinic.elsevierpure.com/en/persons/stephen-maxted-ansell
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.elsevierpure.com ↗ - Other
mayoclinic.org/biographies/ansell-stephen-m-m-d-ph-d/bio-20053059
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mayoclinic.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD (M.B., Ch.B.)
University of Pretoria, South Africa
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aol.amegroups.org ↗ - PhD
University of Pretoria, South Africa
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aol.amegroups.org ↗ - Board Certified
American Board of Internal Medicine, Hematology and Medical Oncology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗
Editorial & leadership roles
journal and society appointments- Chair
Division of Hematology, Mayo Clinic
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →alumniassociation.mayo.edu ↗ - Chair
Lymphoma Disease/Group, Mayo Clinic
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lymphoma.org ↗ - Co-leader
Hematological Malignancies Program, Mayo Clinic Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗
Highly Cited Researcher
Clarivate's annual list, by award category and year- Clinical Medicine20202021verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com ↗
Awards & honors
honors on the public record- 2022 LLS Excellence in Scientific Service Award (Leukemia & Lymphoma Society)
inaugural presentation of this award, one of six scientists honored with 2022 Achievement Awards
2022 - Inaugural recipient
Dorotha W. and Grant L. Sundquist Professorship in Hematologic Malignancies Research, Mayo Clinic
2022verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →alumniassociation.mayo.edu ↗ - 2021 Ernest Beutler Lecture and Prize (American Society of Hematology)
translational/clinical co-recipient, shared with basic-science co-recipient Margaret Shipp, MD (Dana-Farber/Harvard) …
2021verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →alumniassociation.mayo.edu ↗
Secondary affiliations
appointments beyond the home institution- Scientific Advisory Board member
Light Chain Bioscience (NovImmune SA)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lightchainbio.com ↗ - Scientific Advisor
Affimed
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →theorg.com ↗
Media & interviews
press, podcasts and appearances- Guest
Mayo Clinic Talks podcast, episode 'Hodgkin's Lymphoma'
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗ - Guest
Mayo Clinic Talks podcast, episode 'Non-Hodgkin's Lymphoma'
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗ - Video interview subject
VJHemOnc, discusses B-cell malignancy biology and the tumor microenvironment
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →vjhemonc.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
S Rajkumar, MD
Mayo Clinic
Bradley Boeve, MD
Mayo Clinic
Rick Nishimura, MD
Mayo Clinic
Victor Montori, MD
Mayo Clinic